The Latest Breaking News on Pharma

The major indexes fell, with the S&P 500 breaking below bear market lows. Biogen soared on an Alzheimer's drug while Nike dived.

The firm, with bases in the North East and South East, also posted interim results in which losses widened

A recent poll, led by University of Maine professors R. Glover and K. Sporer during July and August 2021 and shared this week, found that of the 400+ Mainers, a majority believe the priority is to treat people who have opioid and general drug use disorders rather than punish them under the…

The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.

According to a scientific study pub

U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's disease

PharmaTher Holdings Ltd. (OTCQB: PHRRF) has published its operational and audited financial results for fiscal year ended May 31, 2022. 

Biopharmaceutical company Bristol-Myers Squibb (BMY) has reported sound financials and possesses a solid upside potential. Given its promising fundamentals, this value stock might be an ideal long-term addition to your portfolio. Keep reading….

Ministry of Finance had said that drug manufacturers will have to deduct 10% tax for the value of free samples of medicines

Reuters

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f